← Open Payments lookup

ERNESTO GUEVARA: Open Payments

NPI 1093342818 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,219 in 66 payments from 11 companies in 2025. Trend: 2023 $1,551 · 2024 $4,946 · 2025 $1,219

Food & beverage: $1,108Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.10$253
Otsuka America Pharmaceutical, Inc.12$253
Alkermes, Inc.12$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$159
ABBVIE INC.15$155
Neurocrine BioSciences, Inc.5$119
Indivior Inc.1$28
E.R. Squibb & Sons, L.L.C.1$27
Lundbeck LLC1$25
Otsuka Pharmaceutical Development & Commercialization, Inc.1$21

Products named: ARISTADA, CAPLYTA, VRAYLAR, INGREZZA, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI, ABILIFY MAINTENA.

Industry payments across FL — which companies pay providers there.